165
Participants
Start Date
September 2, 2021
Primary Completion Date
January 16, 2025
Study Completion Date
January 23, 2025
Empagliflozin 10 MG
Patients are randomized 1:1 to receive either Empagliflozin or matching placebo for 180 days
Placebo
Placebo matches the active drug in appearance, odor and labelling.
Herlev Hospital, Herlev
Odense University Hospital, Odense
Collaborators (1)
Danish Heart Foundation
OTHER
Herlev and Gentofte Hospital
OTHER
University Hospital Bispebjerg and Frederiksberg
OTHER
Hillerod Hospital, Denmark
OTHER
Rigshospitalet, Denmark
OTHER
Jacob Moller
OTHER